Tag - pharmaceuticals

 
Menu
Search
 
August 23, 2025
 

Today's print edition

Home Delivery
Subscribe for more access

PHARMACEUTICALS

Japan Times
WORLD
Nov 9, 2021
Regeneron antibody prevents COVID-19 infections for eight months
The company has asked the U.S. Food and Drug Administration to expand the authorization so the drug can be used to prevent infections.
Japan Times
WORLD / Science & Health
Nov 5, 2021
Pfizer develops COVID-19 pill that cuts hospitalizations and deaths by 89%
The drugmaker claims 'overwhelming efficacy” and plans to submit their findings for emergency authorization as soon as possible.
Japan Times
WORLD
Oct 15, 2021
U.S. FDA advisers back Moderna COVID-19 booster shots for older and high-risk people
If the FDA signs off on Moderna's booster, the U.S. Centers for Disease Control and Prevention will make specific recommendations on who should get the shots.
Japan Times
WORLD
Oct 11, 2021
AstraZeneca drug effective at treating mild COVID-19 symptoms in trial
The antibody cocktail from AstraZeneca may offer a simple way of treating patients before they ever visit the hospital.
Japan Times
WORLD
Oct 11, 2021
Moderna, racing for profits, keeps COVID-19 vaccine out of reach of poor
Moderna has shipped a greater share of its doses to wealthy countries than any other vaccine manufacturer, a data-tracking firm has said.
Japan Times
WORLD
Oct 8, 2021
Pfizer seeks U.S. COVID-19 vaccine clearance for children age 5 to 11
The Food and Drug Administration has set a date of Oct. 26 for its panel of outside advisers to meet and discuss the application.
Japan Times
WORLD / Science & Health / FOCUS
Oct 7, 2021
A Chilean tree holds hope for new vaccines — if supplies last
Quillay trees, technically known as Quillaja saponaria, are rare evergreens native to Chile that have long been used by the indigenous Mapuche people to make soap and medicine.
Japan Times
WORLD
Sep 20, 2021
Pfizer COVID-19 shot safely bolsters antibodies in younger kids
In a trial, two shots of a 10 microgram dose — one-third of the adult shot — produced antibody levels comparable to those seen in a trial of 16- to 25-year-olds who got the adult dose.
Japan Times
JAPAN
Sep 1, 2021
Japan finds another Moderna vial suspected to contain foreign substance
Kanagawa Prefecture said it had put the suspected lot of the firm's COVID-19 vaccine on hold after about 3,790 people had already received shots from the same lot.
Japan Times
JAPAN / Explainer
Aug 30, 2021
Foreign substances in Japan's Moderna shots: Here's what you need to know
Other possibly contaminated batches have been reported in recent days, but experts say health risks are low.
JAPAN / FOCUS
Aug 24, 2021
Japan turns to antibody cocktails as 'new weapon' in fight against pandemic
The government has widened the use of the drug Ronapreve, but some doctors say it needs to go further and make it available to patients isolating at home too.
Japan Times
COMMENTARY / World
Aug 12, 2021
Can Moderna buy its way into the $200 billion club?
Moderna's COVID-19 windfall sees its market valuation surged by more than $100 billion since May.
JAPAN
Aug 11, 2021
Japan backs 'revolutionary' COVID-19 drug Ronapreve to help tame crisis
The antibody cocktail, intended for mildly and moderately ill patients, could in the near future be used to treat those quarantining at home, helping to ease the strain on hospitals.
Japan Times
BUSINESS / Companies
Aug 4, 2021
SoftBank built a $5 billion stake in pharma giant Roche
Roche's diagnostics unit reacted swiftly to the pandemic, and now sales are boosted by its COVID-19 testing business.
Japan Times
COMMENTARY / World
Jul 30, 2021
Legitimate pain research is more crucial than ever
Researchers today say opioids are not only dangerous; they are not a good long-term solution for chronic pain sufferers. The relief tends to wane with time.
JAPAN
Jul 29, 2021
Even with delta surging, experts say two vaccine doses is enough for now
U.S. firm Pfizer Inc. has called for an additional third shot of its COVID-19 vaccine, citing new data showing its efficacy tails off after six months.
Japan Times
WORLD / Science & Health / FOCUS
Jul 21, 2021
Global quest underway to speed up COVID-19 vaccine trials
Researchers are trying to determine just what level of antibodies a vaccine must produce to provide protection against the illness.
Japan Times
WORLD / FOCUS
Jul 16, 2021
World carved up into haves and have-nots by mRNA vaccine access
The cutting-edge technology, which made its debut during the pandemic, has proven more effective than any other in staving off infections and serious illness from the coronavirus.
Japan Times
WORLD
Jul 9, 2021
Pfizer outlines booster plans while regulators signal caution
Pfizer Inc. plans to request U.S. emergency authorization in August for a third booster dose of its COVID-19 vaccine.
Japan Times
WORLD
Jul 9, 2021
Countries using Chinese-made vaccines and AstraZeneca increasingly eye boosters
Officials are being motivated by concerns that delta and other variants appear to be breaking down defenses of vaccines not made from the supereffective messenger RNA technology.
Japan to revise romanization rules for first time in 70 years
The Agency for Cultural Affairs is recommending replacing the government’s long-standing Kunrei system with more widely used Hepburn-style spellings.
JR East cancels luxury train run over crew's boozing
East Japan Railway said Thursday that it will cancel one trip of a luxury overnight sleeper service, which was originally scheduled to depart from Ueno Station in Tokyo on Aug. 30, after crew members were found to have been drinking alcohol on duty.
Demystifying the manufacturing success of China
China’s massive scale, strong education system and competitive local governance have enabled it to reach the technological frontier and dominate high-tech manufacturing despite its low per capita gross domestic product.
Infectious diseases to watch for in Japan this summer amid surge of cases
An illustration of a colony of the Bordetella pertussis bacterium that causes pertussis, or whooping cough. As of Aug. 10, there were 64,467 cases reported this year, according to the latest data from the Japan Institute for Health Security.
103-year-old remembers Soviet attack right after WWII
Shoichi Takahashi holds a photo of himself when he was younger, in Otaru, Hokkaido, on May 17.
Alicia Keys closed Summer Sonic, but J-pop owned it
Summer Sonic’s 2025 lineup demonstrated its strength, showcasing the latest in J-pop, including “new kawaii” act Fruits Zipper.
Big burgers and bigger ambitions for Japan's Burger King
Kazuhiro Nomura, president of BK Japan Holdings, which operates Burger King in Japan
Tokyo crowned No.1 'workation' spot
Workations were a burgeoning trend in the corporate world for years before the COVID-19 pandemic turbocharged it.
Atsushi Kitagawara’s exhibition finds poetry in architecture
The inverted cone, one of Atsushi Kitagawara’s six signature elements in architecture, is a key feature of the Nakamura Keith Haring Collection museum building.
Candidates preparing to make final pitches for Sawamura Award
Hawks pitcher Livan Moinelo has a 1.13 ERA in 19 starts this season.

Podcast

One of the many entrances to the Kabukicho neighborhood in Tokyo’s Shinjuku Ward.
Kabukicho: Tokyo’s ‘stadium of desire’

Longform

Tetsuzo Shiraishi, speaking at The Center of the Tokyo Raids and War Damage, uses a thermos to explain how he experienced the U.S. firebombing of March 1945, when he was just 7 years old.
From ashes to high-rises: A survivor’s account of Tokyo’s postwar past
By Alex K.T. Martin

SUSTAINABLE JAPAN

Looking ahead to Yokohama’s Green × Expo 2027
Looking ahead to Yokohama’s Green × Expo 2027

SPECIAL SUPPLEMENTS note

Read more

SUPPLEMENTS BINDER